The ACC has developed several Shared Decision-Making tools to help patients and clinicians work together when deciding on certain treatment options.

The Heart Failure Decision Aid helps patients diagnosed with heart failure with reduced ejection fraction (HFrEF) choose which renin-angiotensin inhibitor drug, including sacubitril/valsartan, is right for them. Learn more at CardioSmart.org/HFDecisionAids.

For additional resources, check out the Heart Failure and Cardiomyopathies Clinical Topic Collection on ACC.org.

In addition, ACC's TreatHF clinical app helps clinicians confirm which therapies are recommended for symptomatic heart failure patients with reduced ejection fraction and provides guidance for each treatment.